Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
14.07
-0.15 (-1.05%)
At close: Mar 9, 2026
-5.51% (1Y)
| Market Cap | 21.02B |
| Revenue (ttm) | 8.24B |
| Net Income (ttm) | 1.11B |
| Shares Out | 1.49B |
| EPS (ttm) | 0.74 |
| PE Ratio | 19.01 |
| Forward PE | 12.03 |
| Dividend | 0.53 (3.73%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 8,111,720 |
| Average Volume | 9,630,709 |
| Open | 14.19 |
| Previous Close | 14.22 |
| Day's Range | 14.05 - 14.19 |
| 52-Week Range | 13.75 - 17.69 |
| Beta | 0.42 |
| RSI | 33.91 |
| Earnings Date | Mar 20, 2026 |